CRC screening at age 45 What does the modeling suggest?

Size: px
Start display at page:

Download "CRC screening at age 45 What does the modeling suggest?"

Transcription

1 CRC screening at age 45 What does the modeling suggest? Elisabeth Peterse Erasmus University Medical Center, Rotterdam, The Netherlands

2 Possible conflicts of interest No disclosures. Elisabeth Peterse

3 Background In 2016, the CISNET models performed analyses for the United States Preventive Services Task Force Two out of three CISNET models recommended screening from age 45 to 75 years with a 15 year colonoscopy interval. MISCAN-Colon (microsimulation model from Erasmus) recommended screening from age 50 to 75 years with a 10 year colonoscopy interval. 2018: Update screening guideline American Cancer Society Re-evaluation of the optimal screening strategies using MISCAN-Colon Elisabeth Peterse

4 Increase in young-onset CRC While overall incidence is declining, incidence <50 is increasing Rectal Cancers Elisabeth Peterse Siegel et al. JNCI 2017

5 Aim The CISNET models are calibrated to data This period is selected because there was no screening in this period They do not take the recent increase in young-onset CRC into account Research question: Are the optimal age to start screening, age to end screening and screening interval affected by the increase in CRC incidence rate observed in young adults? Elisabeth Peterse

6 Methods Elisabeth Peterse

7 Incorperation higher incidence in MISCAN-Colon Cohort Rate Ratio Set as a reference as this cohort is 40 in 1975 (model is calibrated on ) Used as model input for increased incidence as these are the 40-year-olds in 2015 As it is a cohort effect, we assumed that the current 40 year olds will carry forward an increased CRC risk when they age Provided by Rebecca L. Siegel, American Cancer Society

8 Strategies analyzed We simulated a population of 40-year-olds without previous CRC screening We assumed perfect adherence to screening, diagnostic follow-up and surveillance Screening Modality Age to Start Screening (years) Age to End Screening (years) Screening Interval (years) No. Of (Unique) Strategies No screening 1 (1) Colonoscopy 40,45,50 75,80,85 5,10,15 27 (20) Stool-based tests - Fecal immunochemical test 40,45,50 75,80,85 1,2,3 27 (27) - High-sensitivity guaiac-based fecal occult blood test 40,45,50 75,80,85 1,2,3 27 (27) - Multitarget stool DNA test 40,45,50 75,80,85 1,3,5 27 (27) Flexible sigmoidoscopy 40,45,50 75,80,85 5,10 18 (15) Computed tomographic colonography 40,45,50 75,80,85 5,10 18 (15) Total 145 (132) Elisabeth Peterse

9 Main outcomes Life-years gained (benefit) Number of colonoscopies (burden) Efficiency Ratio= Incremental colonoscopies w.r.t. previous efficient strategy Incremental life-years gained w.r.t. previous efficient strategy Applied efficiency ratio thresholds of 40 Based on the accepted 39 in USPSTF analysis Elisabeth Peterse

10 Results Elisabeth Peterse

11 Efficient Frontier Colonoscopy Screening strategies Elleke Peterse

12 Step 1: In or near the efficient frontier Elleke Peterse

13 Step 2: Effective as current recommendation

14 Step 3: Efficiency ratio < 40 ΔLYG ΔCOL Efficiency Ratio = ΔCOL ΔLYG = 32

15 Step 3: Efficiency ratio < 40 ER=32 ER=48

16 Step 3: Efficiency ratio < 40 ER=32 ER=48

17 Step 4: Select the most effective strategy ER=32 ER=48 Elleke Peterse

18 Model recommendations Modality Age to start screening (years) Age to stop screening (years) Screening interval (years) Stool tests Results per year-olds SIGs CTCs COLs Life-years gained CRC Deaths Averted Colonoscopy Stool test: FIT Flexible Sigmoidoscopy CT colonography Elisabeth Peterse

19 Conclusion Because of the increase in young-onset colorectal cancer, screening initiation at age 45 has a favorable balance between screening benefits and burden. Elisabeth Peterse

20 Acknowledgements Department of Public Health, Erasmus MC, Rotterdam, The Netherlands Reinier G.S. Meester Iris Lansdorp-Vogelaar Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA Ann G. Zauber Jennifer C. Chen American Cancer Society, Atlanta, GA, USA Rebecca L. Siegel Robert A. Smith University of Colorado Cancer Center, Aurora, CO, USA Andrea Dwyer Dennis J. Ahnen Elisabeth Peterse

21 Elisabeth Peterse

22 Population Simulation Model Input MISCAN program Output Results Demography assumptions Natural history assumptions (incl. risk level) Screening assumptions Demography part Natural history part Screening part Cancer incidence and mortality without screening Cancer incidence and mortality with screening Effects of screening Elleke Peterse

23 Important assumptions We modelled the 1975 birth cohort, so we increased incidence by Incidence rate ratios from 1.2, 1.3, 2.3 and 2.4 explored in a sensitivity analyses As it is a cohort effect, we assumed that the current 40 year olds will carry forward an increased CRC risk when they age In a sensitivity analyses, we only increased incidence below age 50 We assumed that the increase in CRC incidence was caused by an increase in adenoma onset We explored faster adenoma progression in a sensitivity analyses Elleke Peterse

24 A cohort effect Increase is higher in whites than in blacks Increase is mainly present in rectal tumors and, to a lesser extend, in distal colon tumors Siegel et al. JNCI 2017, Siegel et al. CA 2017

25 Modality, and Age to Start, Age to End, Interval (years) Stool tests SIGs CTCs COLs LYG CRC Deaths Averted ER = ΔCOL/ ΔLYG ER < Benchmark LYG >= 90% of Benchmark Colonoscopy COL Yes Stool tests FIT Yes No FIT Yes No HSgFOBT Dom. - No FIT-DNA Dom. - No HSgFOBT Dom. - No FIT-DNA Dom - No FIT Yes Yes Yes HSgFOBT Dom. - Yes FIT-DNA No Yes Flexible sigmoidoscopy SIG Yes No SIG Yes Yes Yes CT colonography CTC Yes No CTC Yes Yes Yes Model Recom.

26 Efficient and near-efficient colonoscopy strategies Modality, and Age to Start, Age to End, Interval (years) Stool tests SIGs CTCs COLs LYG CRC Deaths Averted ER = ΔCOL/ ΔLYG COL COL * COL COL * COL COL * COL COL COL COL * COL * COL COL COL Nearefficient

27 Sensitivity analyses

28 Annual Percent Change (APC) in CRC mortality rates among adults aged 20 to 54 years Siegel et al. JAMA 2017

29 Efficient Frontier Stool-based strategies

30 Algorithm to find recommendable strategies

Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies Modeling Study for the US Preventive Services Task Force

Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies Modeling Study for the US Preventive Services Task Force Clinical Review & Education US Preventive Services Task Force MODELING STUDY Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies Modeling Study for the US Preventive Services

More information

ACS Colorectal Cancer Screening Guideline for Average Risk Adults 2018

ACS Colorectal Cancer Screening Guideline for Average Risk Adults 2018 ACS Colorectal Cancer Screening Guideline for Average Risk Adults 2018 1 How are Cancer Screening Guidelines Developed? ACS Guideline Development Process Systematic Evidence Review & Modeling Reports [existing

More information

Cost-effectiveness analysis of a screening programme. Iris Lansdorp-Vogelaar, PhD Department of Public Health Erasmus MC, Rotterdam

Cost-effectiveness analysis of a screening programme. Iris Lansdorp-Vogelaar, PhD Department of Public Health Erasmus MC, Rotterdam Cost-effectiveness analysis of a screening programme Iris Lansdorp-Vogelaar, PhD Department of Public Health Erasmus MC, Rotterdam Criteria of Wilson and Jungner (Bull World Health Organ. 1968) Why cost-effectiveness

More information

Colorectal Cancer Screening

Colorectal Cancer Screening Colorectal Cancer Screening December 5, 2017 Connecticut Cancer Partnership 14th Annual Meeting Xavier Llor, M.D., PhD. Associate Professor of Medicine Co-Director, Cancer Genetics and Prevention Program

More information

Screening Start Age in Light of New ACS Guidelines. Charles Kahi, MD, MS Indiana University Richard L. Roudebush VAMC Indianapolis, Indiana, USA

Screening Start Age in Light of New ACS Guidelines. Charles Kahi, MD, MS Indiana University Richard L. Roudebush VAMC Indianapolis, Indiana, USA Screening Start Age in Light of New ACS Guidelines, MD, MS Indiana University Richard L. Roudebush VAMC Indianapolis, Indiana, USA CRC Screening for Average-Risk Adults: 2018 Guideline Update from the

More information

Colorectal Cancer Screening for Average-Risk Adults: 2018 Guideline Update From the American Cancer Society

Colorectal Cancer Screening for Average-Risk Adults: 2018 Guideline Update From the American Cancer Society CA CANCER J CLIN 2018;00:00 00 Colorectal Cancer Screening for Average-Risk Adults: 2018 Guideline Update From the American Cancer Society Andrew M. D. Wolf, MD 1 ; Elizabeth T. H. Fontham, MPH, DrPH 2

More information

In its October 5, 2015, draft recommendation (draft

In its October 5, 2015, draft recommendation (draft USPSTF Colorectal Cancer Screening Guidelines: An Extended Look at Multi-Year Interval Testing Barry M. Berger, MD, FCAP; Marcus A. Parton, SB; and Bernard Levin, MD, FACP Managed Care & Healthcare Communications,

More information

The New Grade A: USPSTF Updated Colorectal Cancer Screening Guidelines, What does it all mean?

The New Grade A: USPSTF Updated Colorectal Cancer Screening Guidelines, What does it all mean? The New Grade A: USPSTF Updated Colorectal Cancer Screening Guidelines, What does it all mean? Robert A. Smith, PhD Cancer Control, Department of Prevention and Early Detection American Cancer Society

More information

Colorectal Cancer Screening Guideline Issue Brief Updated May 30 th, 2018

Colorectal Cancer Screening Guideline Issue Brief Updated May 30 th, 2018 Colorectal Cancer Screening Guideline Issue Brief Updated May 30 th, 2018 Issue Summary The American Cancer Society has updated its colorectal screening guideline, which have been published in CA: A Journal

More information

Cost-effectiveness of adenoma surveillance - the Dutch guidelines -

Cost-effectiveness of adenoma surveillance - the Dutch guidelines - Cost-effectiveness of adenoma surveillance - the Dutch guidelines - WEO working group adenoma surveillance 20 May, 2016 Iris Lansdorp-Vogelaar, PhD On behalf of the SAP study-group Introduction Adenoma

More information

Colorectal Cancer Screening in Later Life: Blum Center Rounds

Colorectal Cancer Screening in Later Life: Blum Center Rounds Colorectal Cancer Screening in Later Life: Blum Center Rounds OCTOBER 10, 2018 Agenda CRC Screening and Surveillance Recommendation Screening for Colon Cancer later in life Discussion and listening Families

More information

Cancer Screening 2009: New Tests, New Choices

Cancer Screening 2009: New Tests, New Choices Objectives Cancer Screening 2009: New Tests, New Choices UCSF Annual Review in Family Medicine April 21, 2009 Michael B. Potter, MD Professor, Clinical Family and Community Medicine UCSF School of Medicine

More information

COLORECTAL CANCER. Colorectal Cancer (CRC) 3 rd most common cancer in U.S. 3 rd deadliest cancer in U.S. 12/4/2014

COLORECTAL CANCER. Colorectal Cancer (CRC) 3 rd most common cancer in U.S. 3 rd deadliest cancer in U.S. 12/4/2014 The heart and science of medicine. UVMHealth.org/CancerCenter COLORECTAL CANCER Claire Verschraegen, MD Co-Director University of Vermont Cancer Center 1 Colorectal Cancer (CRC) 3 rd most common cancer

More information

CLINICAL PRACTICE GUIDELINE FOR COLORECTAL CANCER SCREENING

CLINICAL PRACTICE GUIDELINE FOR COLORECTAL CANCER SCREENING CLINICAL PRACTICE GUIDELINE FOR COLORECTAL CANCER SCREENING This guideline is designed to assist practitioners by providing the framework for colorectal cancer (CRC) screening, and is not intended to replace

More information

IARC Handbook Volume 17: Colorectal Cancer Screening. Béatrice Lauby-Secretan, PhD on behalf of the IARC Working Group for Volume 17

IARC Handbook Volume 17: Colorectal Cancer Screening. Béatrice Lauby-Secretan, PhD on behalf of the IARC Working Group for Volume 17 IARC Handbook Volume 17: Colorectal Cancer Screening Béatrice Lauby-Secretan, PhD on behalf of the IARC Working Group for Volume 17 IARC Handbooks of Cancer Prevention An important part of cancer prevention

More information

Thank You to Our Sponsors: Evaluations & CE Credits. Featured Speakers. Conflict of Interest & Disclosure Statements

Thank You to Our Sponsors: Evaluations & CE Credits. Featured Speakers. Conflict of Interest & Disclosure Statements Thank You to Our Sponsors: University at Albany School of Public Health NYS Department of Health Evaluations & CE Credits Nursing Contact Hours, CME and CHES credits are available. Please visit www.phlive.org

More information

COLON CANCER SCREENING: AN UPDATE

COLON CANCER SCREENING: AN UPDATE Overview COLON CANCER SCREENING: AN UPDATE Siddharth Verma, DO, JD Rutgers New Jersey Medical School Background Screening Updates in Specific Populations African Americans CRC in the younger age USPSTF

More information

Grand Rounds. Des Moines University. May 5, Durado Brooks, MD, MPH Director, Cancer Control Intervention American Cancer Society

Grand Rounds. Des Moines University. May 5, Durado Brooks, MD, MPH Director, Cancer Control Intervention American Cancer Society Grand Rounds Des Moines University May 5, 2016 Durado Brooks, MD, MPH Director, Cancer Control Intervention American Cancer Society Case Summary Mrs. J is a 56 y o w female complaining of always tired;

More information

Get tested for. Colorectal cancer. Doctors know how to prevent colon or rectal cancer- and you can, too. Take a look inside.

Get tested for. Colorectal cancer. Doctors know how to prevent colon or rectal cancer- and you can, too. Take a look inside. Get tested for Colorectal cancer Doctors know how to prevent colon or rectal cancer- and you can, too. Take a look inside. 1 If you re 50 or older, you need to get tested for colorectal cancer. It s one

More information

Cologuard Screening for Colorectal Cancer

Cologuard Screening for Colorectal Cancer Pending Policies - Medicine Cologuard Screening for Colorectal Cancer Print Number: MED208.056 Effective Date: 08-15-2016 Coverage: I.Cologuard stool DNA testing may be considered medically necessary for

More information

The choice of methods for Colorectal Cancer Screening; The Dutch experience

The choice of methods for Colorectal Cancer Screening; The Dutch experience The choice of methods for Colorectal Cancer Screening; The Dutch experience Monique van Leerdam, Gastroenterologist, NKI-AVL, Amsterdam The Netherlands Colorectal cancer CRC 2 nd cause of cancer related

More information

Improving Outcomes in Colorectal Cancer: The Science of Screening. Colorectal Cancer (CRC)

Improving Outcomes in Colorectal Cancer: The Science of Screening. Colorectal Cancer (CRC) Improving Outcomes in Colorectal Cancer: The Science of Screening Tennessee Primary Care Association October 23, 2014 Durado Brooks, MD, MPH Director, Prostate and Colorectal Cancers Colorectal Cancer

More information

Colon Cancer Screening Past, Present & Future

Colon Cancer Screening Past, Present & Future Colon Cancer Screening Past, Present & Future Steve Lanspa, MD August 25, 2018 Dr. Lanspa has listed no financial interest/arrangement that would be considered a conflict of interest. Learning Objectives

More information

The Dutch bowel cancer screening program Relevant lessions for Ontario

The Dutch bowel cancer screening program Relevant lessions for Ontario The Dutch bowel cancer screening program Relevant lessions for Ontario Ernst J Kuipers Erasmus MC University Medical Center Rotterdam - The Netherlands 1 Ismar Boas (1858 1938) Colorectal cancer screening

More information

National Colonoscopy Study (NCS) Screening Colonoscopy versus Annual Fecal Occult Blood Test NCT

National Colonoscopy Study (NCS) Screening Colonoscopy versus Annual Fecal Occult Blood Test NCT National Colonoscopy Study (NCS) Screening Colonoscopy versus Annual Fecal Occult Blood Test NCT 00102011 Ann Zauber Sidney Winawer, Michael O Brien, John Allen, Andrew Feld, Glenn Mills, Robin Mendelsohn,

More information

HOW TO EVALUATE ACTIVITIES INTENDED TO INCREASE AWARENESS AND USE OF COLORECTAL CANCER SCREENING. Using your toolkit to conduct an evaluation

HOW TO EVALUATE ACTIVITIES INTENDED TO INCREASE AWARENESS AND USE OF COLORECTAL CANCER SCREENING. Using your toolkit to conduct an evaluation EVALUATION TOOLKIT HOW TO EVALUATE ACTIVITIES INTENDED TO INCREASE AWARENESS AND USE OF COLORECTAL CANCER SCREENING Using your toolkit to conduct an evaluation Welcome Mary Doroshenk, MA Director National

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Zauber AG, Winawer SJ, O Brien MJ, et al. Colonoscopic polypectomy

More information

Fecal Occult Blood Testing When Colonoscopy Capacity is Limited

Fecal Occult Blood Testing When Colonoscopy Capacity is Limited DOI: 10.1093/jnci/djr385 Advance Access publication on November 9, 2011. The Author 2011. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

More information

Background and Rationale for Gipson bill AB The imperative for colonoscopy after a positive FOBT (Fecal Occult Blood Test)

Background and Rationale for Gipson bill AB The imperative for colonoscopy after a positive FOBT (Fecal Occult Blood Test) Background and Rationale for Gipson bill AB 1763 The imperative for colonoscopy after a positive FOBT (Fecal Occult Blood Test) The Affordable Care Act (ACA) requires all private insurers (except grandfathered

More information

Updates in Colorectal Cancer Screening & Prevention

Updates in Colorectal Cancer Screening & Prevention Updates in Colorectal Cancer Screening & Prevention Swati G. Patel, MD MS Assistant Professor of Medicine Division of Gastroenterology & Hepatology Gastrointestinal Cancer Risk and Prevention Clinic University

More information

Colorectal Cancer Screening. Dr Kishor Muniyappa 2626 Care Drive, Suite 101 Tallahassee, FL Ph:

Colorectal Cancer Screening. Dr Kishor Muniyappa 2626 Care Drive, Suite 101 Tallahassee, FL Ph: Colorectal Cancer Screening Dr Kishor Muniyappa 2626 Care Drive, Suite 101 Tallahassee, FL 32308 Ph: 850-297-0351 What we ll be talking about How common is colorectal cancer? What is colorectal cancer?

More information

Technical Considerations: the past, present and future of simulation modeling of colorectal cancer

Technical Considerations: the past, present and future of simulation modeling of colorectal cancer Technical Considerations: the past, present and future of simulation modeling of colorectal cancer Siddhartha Nambiar, Rachel Townsley, Maria Mayorga North Carolina State University Kristen Hassmiller

More information

The U.S. Preventive Services Task Force (USPSTF) makes

The U.S. Preventive Services Task Force (USPSTF) makes Annals of Internal Medicine Clinical Guidelines Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement U.S. Preventive Services Task Force* Description: Update of

More information

Joint Session with ACOFP and Cancer Treatment Centers of America (CTCA): Cancer Screening: Consensus & Controversies. Ashish Sangal, M.D.

Joint Session with ACOFP and Cancer Treatment Centers of America (CTCA): Cancer Screening: Consensus & Controversies. Ashish Sangal, M.D. Joint Session with ACOFP and Cancer Treatment Centers of America (CTCA): Cancer Screening: Consensus & Controversies Ashish Sangal, M.D. Cancer Screening: Consensus & Controversies Ashish Sangal, MD Director,

More information

Colorectal Cancer Screening: Cost-Effectiveness and Adverse events October, 2005

Colorectal Cancer Screening: Cost-Effectiveness and Adverse events October, 2005 Colorectal Cancer Screening: Cost-Effectiveness and Adverse events October, 2005 David Lieberman MD Chief, Division of Gastroenterology Oregon Health and Science University Portland VAMC Portland, Oregon

More information

Colorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society

Colorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society Colorectal Cancer: Preventable, Beatable, Treatable American Cancer Society Reviewed/Revised May 2018 What we ll be talking about How common is colorectal cancer? What is colorectal cancer? What causes

More information

Quality ID #113 (NQF 0034): Colorectal Cancer Screening National Quality Strategy Domain: Effective Clinical Care

Quality ID #113 (NQF 0034): Colorectal Cancer Screening National Quality Strategy Domain: Effective Clinical Care Quality ID #113 (NQF 0034): Colorectal Cancer Screening National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY MEASURE TYPE: Process DESCRIPTION: Percentage

More information

Colorectal Cancer Disparities: Addressing the Challenge

Colorectal Cancer Disparities: Addressing the Challenge Colorectal Cancer Disparities: Addressing the Challenge Inaugural Cancer Disparities Conference The Ohio State University Wexner Medical Center March 28, 2015 Durado Brooks, MD, MPH Cancer Disparities:

More information

Staging and survival of colorectal cancer (CRC) in octogenarians: Nationwide Study of US Veterans

Staging and survival of colorectal cancer (CRC) in octogenarians: Nationwide Study of US Veterans Original Article Staging and survival of colorectal cancer (CRC) in octogenarians: Nationwide Study of US Veterans Gurjiwan Sing Virk 1, Mikram Jafri 2, Syed Mehdi 3, Christopher Ashley 4 1 Department

More information

Colon Cancer Screening. A Provider Opinion Survey

Colon Cancer Screening. A Provider Opinion Survey Colon Cancer Screening A Provider Opinion Survey 1. Background Information What is colon cancer? Who needs to be screened? Colorectal Cancer» Presence of abnormal cells in the colon or rectum that divide

More information

Stool DNA Testing to Screen for Colorectal Cancer in the Medicare Population A Cost-Effectiveness Analysis

Stool DNA Testing to Screen for Colorectal Cancer in the Medicare Population A Cost-Effectiveness Analysis Article Annals of Internal Medicine Stool DNA Testing to Screen for Colorectal Cancer in the Medicare Population A Cost-Effectiveness Analysis Iris Lansdorp-Vogelaar, PhD; Karen M. Kuntz, ScD; Amy B. Knudsen,

More information

Objectives. Definitions. Colorectal Cancer Screening 5/8/2018. Payam Afshar, MS, MD Kaiser Permanente, San Diego. Colorectal cancer background

Objectives. Definitions. Colorectal Cancer Screening 5/8/2018. Payam Afshar, MS, MD Kaiser Permanente, San Diego. Colorectal cancer background Colorectal Cancer Screening Payam Afshar, MS, MD Kaiser Permanente, San Diego Objectives Colorectal cancer background Colorectal cancer screening populations Colorectal cancer screening modalities Colonoscopy

More information

Colorectal Cancer Screening. Daniel C. Chung, MD GI Unit and GI Cancer Genetics Service Massachusetts General Hospital

Colorectal Cancer Screening. Daniel C. Chung, MD GI Unit and GI Cancer Genetics Service Massachusetts General Hospital Colorectal Cancer Screening Daniel C. Chung, MD GI Unit and GI Cancer Genetics Service Massachusetts General Hospital March, 2018 CRC Epidemiology 4th most common malignancy in US (136,000 cases/yr) 2nd

More information

COLORECTAL CANCER SCREENING &THE FECAL IMMUNOCHEMICAL TEST (FIT) MATHEW ESTEY, PHD, FCACB CLINICAL CHEMIST

COLORECTAL CANCER SCREENING &THE FECAL IMMUNOCHEMICAL TEST (FIT) MATHEW ESTEY, PHD, FCACB CLINICAL CHEMIST COLORECTAL CANCER SCREENING &THE FECAL IMMUNOCHEMICAL TEST (FIT) MATHEW ESTEY, PHD, FCACB CLINICAL CHEMIST MATHEW.ESTEY@DYNALIFEDX.COM FACULTY /PRESENTER DISCLOSURE FACULTY: MATHEW ESTEY RELATIONSHIPS

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Meester R.G.S, Doubeni CA, Lansdorp-Vogelaar, et al. Variation in adenoma detection rate and the lifetime benefits and cost of colorectal cancer screening: a microsimulation

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Analysis of Human DNA in Stool Samples as a Page 1 of 11 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Analysis of Human DNA in Stool Samples as a Technique for

More information

Early detection and screening for colorectal neoplasia

Early detection and screening for colorectal neoplasia Early detection and screening for colorectal neoplasia Robert S. Bresalier Department of Gastroenterology, Hepatology and Nutrition. The University of Texas. MD Anderson Cancer Center. Houston, Texas U.S.A.

More information

Citation for published version (APA): Wijkerslooth de Weerdesteyn, T. R. (2013). Population screening for colorectal cancer by colonoscopy

Citation for published version (APA): Wijkerslooth de Weerdesteyn, T. R. (2013). Population screening for colorectal cancer by colonoscopy UvA-DARE (Digital Academic Repository) Population screening for colorectal cancer by colonoscopy de Wijkerslooth, T.R. Link to publication Citation for published version (APA): Wijkerslooth de Weerdesteyn,

More information

Learning and Earning with Gateway Professional Education CME/CEU Webinar Series

Learning and Earning with Gateway Professional Education CME/CEU Webinar Series Learning and Earning with Gateway Professional Education CME/CEU Webinar Series Best Practices for Colorectal Cancer Screening March 14, 2018 12:00pm 1:00pm Robert A. Smith, PhD Vice President, Cancer

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Analysis of Human DNA in Stool Samples as a Page 1 of 12 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Analysis of Human DNA in Stool Samples as a Technique for

More information

Colorectal Cancer Screening

Colorectal Cancer Screening Colorectal Cancer Screening Colonoscopy is the gold standard for colorectal cancer screening 2 Focus on Colorectal Cancer Screening at Piedmont Healthcare Screening for colorectal cancer saves lives. Of

More information

Colorectal Cancer Screening and Risk Assessment Workflow. Documentation Guide for Health Center NextGen Users

Colorectal Cancer Screening and Risk Assessment Workflow. Documentation Guide for Health Center NextGen Users Colorectal Cancer Screening and Risk Assessment Workflow Documentation Guide for Health Center NextGen Users Colorectal Cancer Screening and Risk Assessment Workflow and Documentation Guide for Health

More information

Study population The study population comprised a hypothetical cohort of 50-year-olds at average risk of CRC.

Study population The study population comprised a hypothetical cohort of 50-year-olds at average risk of CRC. Colon cancer prevention in Italy: cost-effectiveness analysis with CT colonography and endoscopy Hassan C, Zullo A, Laghi A, Reitano I, Taggi F, Cerro P, Iafrate F, Giustini M, Winn S, Morini S Record

More information

CRC Risk Factors. U.S. Adherence Rates Cancer Screening. Genetic Model of Colorectal Cancer. Epidemiology and Clinical Consequences of CRC

CRC Risk Factors. U.S. Adherence Rates Cancer Screening. Genetic Model of Colorectal Cancer. Epidemiology and Clinical Consequences of CRC 10:45 11:45 am Guide to Colorectal Cancer Screening SPEAKER Howard Manten M.D. Presenter Disclosure Information The following relationships exist related to this presentation: Howard Manten MD: No financial

More information

Colorectal Cancer Screening in Washington State

Colorectal Cancer Screening in Washington State Colorectal Cancer Screening in Washington State Susie Dade, Deputy Director, Washington Health Alliance March 25, 2016 Colorectal Cancer Roundtable Outline About the Alliance How we re doing in Washington

More information

IEHP UM Subcommittee Approved Authorization Guidelines Colorectal Cancer Screening with Cologuard TM for Medicare Beneficiaries

IEHP UM Subcommittee Approved Authorization Guidelines Colorectal Cancer Screening with Cologuard TM for Medicare Beneficiaries for Medicare Beneficiaries Policy: Based on our review of the available evidence, the IEHP UM Subcommittee adopts the use of Cologuard TM - a multi-target stool DNA test as a colorectal cancer screening

More information

Guidelines for Colonoscopy Surveillance After Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer

Guidelines for Colonoscopy Surveillance After Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer Guidelines for Colonoscopy Surveillance After Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer David A. Lieberman, 1 Douglas K. Rex, 2 Sidney J. Winawer,

More information

Colorectal Cancer Screening and Surveillance

Colorectal Cancer Screening and Surveillance 1 Colorectal Cancer Screening and Surveillance Jeffrey Lee MD, MAS Assistant Clinical Professor of Medicine University of California, San Francisco jeff.lee@ucsf.edu Objectives Review the various colorectal

More information

Increasing Colorectal Cancer Screening Rates Why it s not as easy as you ve been told

Increasing Colorectal Cancer Screening Rates Why it s not as easy as you ve been told INCREASING COLORECTAL CANCER SCREENING IN NYS Increasing Colorectal Cancer Screening Rates Why it s not as easy as you ve been told 5/15/17 Syracuse, NY Martin C. Mahoney, MD, PhD Roswell Park Cancer Institute

More information

11/9/2015 OUTLINE. Quality Indicators for the Doctor Performing Screening Colonoscopy: What you should expect from your Endoscopist

11/9/2015 OUTLINE. Quality Indicators for the Doctor Performing Screening Colonoscopy: What you should expect from your Endoscopist Quality Indicators for the Doctor Performing Screening Colonoscopy: What you should expect from your Endoscopist Anil K Sharma MD FACP Professor of Clinical Medicine, University of Rochester Chief of Gastroenterology,

More information

Financial Disclosers

Financial Disclosers Slide 1 Colorectal Cancer Screening Jason Hemming, MD NESGNA November 15, 2014 Slide 2 Bio Slide 3 Financial Disclosers I have no actual or potential conflict of interest relation to this presentation

More information

Colon Cancer Screening. Layth Al-Jashaami, MD GI Fellow, PGY 4

Colon Cancer Screening. Layth Al-Jashaami, MD GI Fellow, PGY 4 Colon Cancer Screening Layth Al-Jashaami, MD GI Fellow, PGY 4 -Colorectal cancer (CRC) is a common and lethal cancer. -It has the highest incidence among GI cancers in the US, estimated to be newly diagnosed

More information

Quality ID #113 (NQF 0034): Colorectal Cancer Screening National Quality Strategy Domain: Effective Clinical Care

Quality ID #113 (NQF 0034): Colorectal Cancer Screening National Quality Strategy Domain: Effective Clinical Care Quality ID #113 (NQF 0034): Colorectal Cancer Screening National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION:

More information

Colorectal cancer screening

Colorectal cancer screening 26 Colorectal cancer screening BETHAN GRAF AND JOHN MARTIN Colorectal cancer is theoretically a preventable disease and is ideally suited to a population screening programme, as there is a long premalignant

More information

Colorectal Cancer Screening in Ohio CHCs. Ohio Association of Community Health Centers

Colorectal Cancer Screening in Ohio CHCs. Ohio Association of Community Health Centers Colorectal Cancer Screening in Ohio CHCs Ohio Association of Community Health Centers 2 1/29/2015 Your Speakers Dr. Ted Wymyslo Ashley Ballard Randy Runyon 3 1/29/2015 Facts 3 rd most common cancer in

More information

Debate: General surveillance/screening for colon cancer in a resource constrained environment is imperative

Debate: General surveillance/screening for colon cancer in a resource constrained environment is imperative Debate: General surveillance/screening for colon cancer in a resource constrained environment is imperative Dr. Meryl Oyomno Department of surgery, University of Pretoria INTRODUCTION Screening is the

More information

Increasing Colorectal Cancer Screening in Wyoming. Allie Bain, MPH Outreach & Education Supervisor Wyoming Integrated Cancer Services Program

Increasing Colorectal Cancer Screening in Wyoming. Allie Bain, MPH Outreach & Education Supervisor Wyoming Integrated Cancer Services Program Increasing Colorectal Cancer Screening in Wyoming Allie Bain, MPH Outreach & Education Supervisor Wyoming Integrated Cancer Services Program Overview What is colorectal cancer? What are risk factors for

More information

How to start a screening Program? WEO Colorectal Cancer Screening Committee Meeting Brasilia Nov R. Sáenz, FACG,FASGE

How to start a screening Program? WEO Colorectal Cancer Screening Committee Meeting Brasilia Nov R. Sáenz, FACG,FASGE How to start a screening Program? WEO Colorectal Cancer Screening Committee Meeting Brasilia Nov 11 2017 R. Sáenz, FACG,FASGE Wheel has been discovered already Policy Planning Thanks to GBD Big Data CRC

More information

CT Colonography. A Radiologist s View of the Colon from Outside-In. Donny Baek, MD

CT Colonography. A Radiologist s View of the Colon from Outside-In. Donny Baek, MD CT Colonography A Radiologist s View of the Colon from Outside-In Donny Baek, MD Computed Tomography (CT) CT Image Reconstruction CT Image Reconstruction CT Image Reconstruction Colorectal Cancer Annual

More information

Colon Cancer Screening and Surveillance. Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011

Colon Cancer Screening and Surveillance. Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011 Colon Cancer Screening and Surveillance Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011 Colorectal Cancer Preventable cancer Number 2 cancer killer in the USA Often curable if detected

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Virtual Colonoscopy / CT Colonography Page 1 of 19 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Virtual Colonoscopy / CT Colonography Professional Institutional

More information

Colorectal Cancer Screening: Colonoscopy, Potential and Pitfalls. Disclosures: None. CRC: still a major public health problem

Colorectal Cancer Screening: Colonoscopy, Potential and Pitfalls. Disclosures: None. CRC: still a major public health problem Colorectal Cancer Screening: Colonoscopy, Potential and Pitfalls Disclosures: None Jonathan P. Terdiman, M.D. Professor of Clinical Medicine University of California, San Francisco CRC: still a major public

More information

Screening for Colorectal Cancer: A Systematic Review for the U.S. Preventive Services Task Force

Screening for Colorectal Cancer: A Systematic Review for the U.S. Preventive Services Task Force Evidence Synthesis Number 135 Screening for Colorectal Cancer: A Systematic Review for the U.S. Preventive Services Task Force Prepared for: Agency for Healthcare Research and Quality U.S. Department of

More information

OHSU Health System Office of Clinical Integration and Evidence-Based Practice Colorectal Cancer Screening Evidence Summary

OHSU Health System Office of Clinical Integration and Evidence-Based Practice Colorectal Cancer Screening Evidence Summary OHSU Health System Office of Clinical Integration and Evidence-Based Practice Colorectal Cancer Screening Evidence Summary Date started: April 2017 Date completed: October 2017 Content Expert Team Members:

More information

ACTIVITY DISCLAIMER DISCLOSURE. Alvin B. Lin, MD, FAAFP. Audience Engagement System Step 1 Step 2 Step 3. Learning Objectives.

ACTIVITY DISCLAIMER DISCLOSURE. Alvin B. Lin, MD, FAAFP. Audience Engagement System Step 1 Step 2 Step 3. Learning Objectives. ACTIVITY DISCLAIMER Colorectal Cancer Alvin B. Lin, MD, FAAFP The material presented here is being made available by the American Academy of Family Physicians for educational purposes only. Please note

More information

References Cleveland Clinic. Diseases and Conditions. Colorectal Cancer Overview. 29 October 2013

References Cleveland Clinic. Diseases and Conditions. Colorectal Cancer Overview. 29 October 2013 Colo-Alert Only available DNA based rapid test for early colorectal cancer detection. The earlier colon cancer is found, the easier it is to treat. This is why regular screening is worthwhile it has the

More information

2017 CANCER ANNUAL REPORT

2017 CANCER ANNUAL REPORT 2017 CANCER ANNUAL REPORT A WORD FROM OUR LEADERSHIP We are pleased to present our 2017 Annual Report highlighting advances in state of the art cancer care at the Roper St. Francis Cancer Program. Our

More information

Guidelines for the Early Detection of Cancer

Guidelines for the Early Detection of Cancer Guidelines for the Early Detection of Cancer The American Cancer Society recommends these cancer screening guidelines for most adults. Screening tests are used to find cancer before a person has any symptoms.

More information

Screening for Colorectal Cancer in the Elderly. The Broad Perspective

Screening for Colorectal Cancer in the Elderly. The Broad Perspective Screening for Colorectal Cancer in the Elderly Charles J. Kahi, MD, MSCR Indiana University School of Medicine Richard L. Roudebush VA Medical Center Indianapolis, Indiana ACG Regional Midwest Course Symposium

More information

Page 1. Cancer Screening for Women I have no conflicts of interest. Overview. Breast, Colon, and Lung Cancer. Jeffrey A.

Page 1. Cancer Screening for Women I have no conflicts of interest. Overview. Breast, Colon, and Lung Cancer. Jeffrey A. Cancer Screening for Women 2017 Breast, Colon, and Lung Cancer Jeffrey A. Tice, MD Professor of Medicine Division of General Internal Medicine University of California, San Francisco I have no conflicts

More information

Cancer Screening. Charuwan Akewanlop, MD Division of Medical Oncology Department of Medicine Faculty of Medicine Siriraj Hospital

Cancer Screening. Charuwan Akewanlop, MD Division of Medical Oncology Department of Medicine Faculty of Medicine Siriraj Hospital Cancer Screening Charuwan Akewanlop, MD Division of Medical Oncology Department of Medicine Faculty of Medicine Siriraj Hospital Outline Definition and principles of cancer screening Cancer incidence and

More information

The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening

The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening 2 The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening 30 Chapter 2 Abstract A general model for evaluation of colorectal cancer screening has been implemented in the microsimulation

More information

Pharmacogenomic and Metabolite Markers for Patients Treated with Thiopurines

Pharmacogenomic and Metabolite Markers for Patients Treated with Thiopurines Pharmacogenomic and Metabolite Markers for Patients Treated with Thiopurines Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana,

More information

Cancer Screening & Prevention. Dr. Jamey Burton, MD, FAAFP

Cancer Screening & Prevention. Dr. Jamey Burton, MD, FAAFP Cancer Screening & Prevention Dr. Jamey Burton, MD, FAAFP Cervical Cancer Breast Cancer Colon Cancer Prostate Cancer Lung Cancer How common is cervical cancer? What causes it? What screening is needed?

More information

Colorectal Cancer Screening. Paul Berg MD

Colorectal Cancer Screening. Paul Berg MD Colorectal Cancer Screening Paul Berg MD What is clinical integration? AMA Definition The means to facilitate the coordination of patient care across conditions, providers, settings, and time in order

More information

Cancer Facts for Men FOR REVIEW ONLY

Cancer Facts for Men FOR REVIEW ONLY Cancer Facts for Men Prostate cancer The chance of getting prostate cancer goes up as a man gets older. Most prostate cancers are found in men over the age of 65. For reasons that are still unknown, African

More information

Appendix 1 This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.

Appendix 1 This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix 1 This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Cenin DR, St John DJB, Ledger MJN, et al. Optimising the

More information

Screening & Surveillance Guidelines

Screening & Surveillance Guidelines Chapter 2 Screening & Surveillance Guidelines I. Eligibility Coloradans ages 50 and older (average risk) or under 50 at elevated risk for colon cancer (personal or family history) that meet the following

More information

ONCOLOGY OUTCOMES REPORT

ONCOLOGY OUTCOMES REPORT 2017 EVANGELICAL COMMUNITY HOSPITAL ONCOLOGY OUTCOMES REPORT One Hospital Drive, Lewisburg, PA 17837 570-522-2000 evanhospital.com Cancer Screening The Commission on Cancer requires annual dissemination

More information

Setting The setting was primary and secondary care. The economic study was carried out in Taiwan.

Setting The setting was primary and secondary care. The economic study was carried out in Taiwan. Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries Wu G H, Wang Y W, Yen A M, Wong J M, Lai H C, Warwick J, Chen T H Record Status This

More information

They know how to prevent colon cancer

They know how to prevent colon cancer They know how to prevent colon cancer and you can, too. Take a look inside. If you re 50 or older, you need to get tested for colon cancer. It s one cancer that can actually be prevented! Colon cancer:

More information

How to Increase Preventive Screening Rates in Practice: An Action Plan for Implementing A Primary Care Clinician s Evidence-Based Toolbox and Guide

How to Increase Preventive Screening Rates in Practice: An Action Plan for Implementing A Primary Care Clinician s Evidence-Based Toolbox and Guide How to Increase Preventive Screening Rates in Practice: An Action Plan for Implementing A Primary Care Clinician s Evidence-Based Toolbox and Guide CRC Toolkit and Guide Available at http://www.cancer.org/aspx/pcmanual/pcm.swf

More information

Colorectal Cancer Screening: The Science Behind the Guidelines. CRC Incidence North Dakota. Colorectal Cancer (CRC) CRC Incidence North Dakota

Colorectal Cancer Screening: The Science Behind the Guidelines. CRC Incidence North Dakota. Colorectal Cancer (CRC) CRC Incidence North Dakota Reaching 80% Screened For Colorectal Cancer by 2018: Using Systems Change to Increase Cancer Screening Colorectal Cancer Screening: The Science Behind the Guidelines September 2017 Jeff Hostetter, MD Based

More information

Colorectal Cancer Screening

Colorectal Cancer Screening Tool 2.1 Cancer Screening Basic Fact Sheet Are You at High Risk? Your risk for colorectal cancer may be higher than average if: stomach You or a close relative have had colorectal polyps or colorectal

More information

2. Describe pros/cons of screening interventions (including colonoscopy, CT colography, fecal tests)

2. Describe pros/cons of screening interventions (including colonoscopy, CT colography, fecal tests) Learning Objectives 1. Review principles of colon adenoma/cancer biology that permit successful prevention regimes 2. Describe pros/cons of screening interventions (including colonoscopy, CT colography,

More information

Diagnostics for the early detection and prevention of colon cancer. Publication of DeeP-C Study Data in New England Journal of Medicine March 2014

Diagnostics for the early detection and prevention of colon cancer. Publication of DeeP-C Study Data in New England Journal of Medicine March 2014 Diagnostics for the early detection and prevention of colon cancer Publication of DeeP-C Study Data in New England Journal of Medicine March 2014 Safe Harbor Statement Certain statements made in this presentation

More information

The Use of Quality Measures in Colorectal Cancer Screening

The Use of Quality Measures in Colorectal Cancer Screening The Use of Quality Measures in Colorectal Cancer Screening Susan Hutfless PhD Johns Hopkins University School of Medicine, Division of Gastroenterology & Johns Hopkins Bloomberg School of Public Health,

More information

Medicare Shared Savings Program Accountable Care Organization (ACO) Measures Deep Dive Series

Medicare Shared Savings Program Accountable Care Organization (ACO) Measures Deep Dive Series Medicare Shared Savings Program Accountable Care Organization (ACO) Measures Deep Dive Series Preventive Care and Screening (PREV-6): Measure 19 Colorectal Cancer Screening ACO_QRM19PPTv9_0518_IA Approved

More information

Cancer Screenings and Early Diagnostics

Cancer Screenings and Early Diagnostics Cancer Screenings and Early Diagnostics Ankur R. Parikh, D.O. Medical Director, Center for Advanced Individual Medicine Hematologist/Medical Oncologist Atlantic Regional Osteopathic Convention April 6

More information

ACG Clinical Guideline: Colorectal Cancer Screening

ACG Clinical Guideline: Colorectal Cancer Screening ACG Clinical Guideline: Colorectal Cancer Screening Douglas K. Rex, MD, FACG 1, David A. Johnson, MD, FACG 2, Joseph C. Anderson, MD 3, Phillip S. Schoenfeld, MD, MSEd, MSc (Epi), FACG 4, Carol A. Burke,

More information